Aims Inflammation plays a central role in the pathogenesis and clinical manifestations of
atherosclerosis. Randomized controlled trials have investigated the potential benefit of …

Background Inflammation plays a pivotal role in coronary artery disease (CAD). The anti‐
inflammatory drug colchicine seems to reduce ischemic events in patients with CAD. So far …

Methods We searched PubMed/MEDLINE, Cochrane library, and Embase databases
(inception through 28 February 2020) for RCTs evaluating colchicine in CAD patients. The …

Background Inflammatory plays a key role in the development of coronary artery disease
(CAD). Colchicine as an anti-inflammatory treatment for CAD has attracted much attention …

Background: Evidence from recent studies has shown the benefits of colchicine for patients
with coronary artery disease. The aim was to assess the effect of colchicine treatment on …

Background: Recent studies have revealed the benefits of using colchicine, a drug with anti-
inflammatory properties, in coronary artery disease (CAD). This study systematically …

Background Reduction of inflammation with colchicine has emerged as a therapeutic option
for secondary prevention of cardiovascular disease (CVD) in patients with coronary artery …

Colchicine has shown potential therapeutic benefits in cardiovascular conditions owing to its
broad anti-inflammatory properties. Here, we performed a meta-analysis to determine the …

Purpose Colchicine is an ancient anti-inflammatory drug. In recent years, an increasing
number of studies have shown that colchicine improves the prognosis of patients with …

Aims Recent randomized trials demonstrated a benefit of low-dose colchicine added to
guideline-based treatment in patients with recent myocardial infarction or chronic coronary …